Foralumab reduced microglial activity in people with nonactive SPMS, and this was linked to reductions in proinflammatory ...
Neffy nasal spray shows comparable efficacy to IM epinephrine for type I allergic reactions, with 92.3% symptom resolution after 1 dose.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results